Pharma major Dr Reddy’s Laboratories is recalling its muscle relaxant tizanidine tablets from the US market due to labelling issues.

The recall was initiated voluntarily by the Hyderabad-based company, as per an intimation from the company to the US Food and Drug Administration.

Over 1.17 lakh bottles are being recalled from the market. Each bottle has 150 tablets.

As per the US regulator, the recall is dubbed as class III recall, in which adverse health impact is unlikely.

Dr Reddy’s scrip gained 0.54 per cent on the Bombay Stock Exchange and is trading at Rs 1,897 by the lunch hour on Friday.

(This article was published on April 12, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.